Kao SC - Search Results

1

Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board.

Kao SC, Vardy J, Chatfield M, Corte P, Pavlakis N, Clarke C, van Zandwijk N, Clarke S. Kao SC, et al. Clin Lung Cancer. 2013 Jan;14(1):70-7. doi: 10.1016/j.cllc.2012.03.011. Epub 2012 Jun 1. Clin Lung Cancer. 2013. PMID: 22658812

2

Use of chemotherapy at end of life in oncology patients.

Kao S, Shafiq J, Vardy J, Adams D. Kao S, et al. Ann Oncol. 2009 Sep;20(9):1555-1559. doi: 10.1093/annonc/mdp027. Epub 2009 May 25. Ann Oncol. 2009. PMID: 19468033 Free article.

3

Pleural well-differentiated papillary mesothelioma: a case report.

Kao S, Mahon K, Lin B, Rutland J, Pawsey C, McCaughan B, Beale P. Kao S, et al. J Thorac Oncol. 2009 Jul;4(7):920-2. doi: 10.1097/JTO.0b013e3181a97dc3. J Thorac Oncol. 2009. PMID: 19550246 Free article.

4

Predictive markers for haematological toxicity of pemetrexed.

Kao SC, Phan VH, Clarke SJ. Kao SC, et al. Curr Drug Targets. 2010 Jan;11(1):48-57. doi: 10.2174/138945010790031072. Curr Drug Targets. 2010. PMID: 19839928 Review.

5

Malignant mesothelioma.

Kao SC, Reid G, Lee K, Vardy J, Clarke S, van Zandwijk N. Kao SC, et al. Intern Med J. 2010 Nov;40(11):742-50. doi: 10.1111/j.1445-5994.2010.02223.x. Intern Med J. 2010. PMID: 20298508 Review.

6

Patient and oncologist estimates of survival in advanced cancer patients.

Kao SC, Butow P, Bray V, Clarke SJ, Vardy J. Kao SC, et al. Psychooncology. 2011 Feb;20(2):213-8. doi: 10.1002/pon.1727. Psychooncology. 2011. PMID: 20878829

7

High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy.

Kao SC, Pavlakis N, Harvie R, Vardy JL, Boyer MJ, van Zandwijk N, Clarke SJ. Kao SC, et al. Clin Cancer Res. 2010 Dec 1;16(23):5805-13. doi: 10.1158/1078-0432.CCR-10-2245. Epub 2010 Oct 18. Clin Cancer Res. 2010. PMID: 20956618

8

Validation of tissue microarray technology in malignant pleural mesothelioma.

Kao SC, Lee K, Armstrong NJ, Clarke S, Vardy J, van Zandwijk N, Reid G, Burn J, McCaughan BC, Henderson DW, Klebe S. Kao SC, et al. Pathology. 2011 Feb;43(2):128-32. doi: 10.1097/PAT.0b013e328342016c. Pathology. 2011. PMID: 21233673

9

Use of inflammatory markers to guide cancer treatment.

Clarke SJ, Chua W, Moore M, Kao S, Phan V, Tan C, Charles K, McMillan DC. Clarke SJ, et al. Clin Pharmacol Ther. 2011 Sep;90(3):475-8. doi: 10.1038/clpt.2011.122. Epub 2011 Jul 20. Clin Pharmacol Ther. 2011. PMID: 21775983 Review. No abstract available.

10

Haemolysis during sample preparation alters microRNA content of plasma.

Kirschner MB, Kao SC, Edelman JJ, Armstrong NJ, Vallely MP, van Zandwijk N, Reid G. Kirschner MB, et al. Among authors: kao sc. PLoS One. 2011;6(9):e24145. doi: 10.1371/journal.pone.0024145. Epub 2011 Sep 1. PLoS One. 2011. PMID: 21909417 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

494 results

Search Page

Filters